U.S. Specialized REITs Stock News

NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Lands A $35 Million Contract, Is The Stock Still Cheap?

ICF International (ICFI) just paired its second quarter earnings release with a new US$35 million energy efficiency contract from Entergy Louisiana. Both updates give you fresh data on profit trends and contract momentum. See our latest analysis for ICF International. The recent Entergy Louisiana contract and the second quarter earnings update appear to have coincided with stronger interest in ICF International, with the share price at US$85.31 and a 90 day share price return of 22.55%...
NYSE:PFE
NYSE:PFEPharmaceuticals

Why Pfizer (PFE) Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss

In the second quarter of 2026, Pfizer reported revenue of US$15,034 million, up from US$14,653 million a year earlier, but swung from net income of US$2,910 million to a net loss of US$248 million after recording US$4.30 billion in non-cash intangible asset impairments. Despite these impairments, Pfizer raised its 2026 revenue guidance midpoint to US$61.50 billion and highlighted encouraging late-stage pipeline progress, including positive Phase 3 results for its vitiligo therapy...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings (DKNG) Stock Looks Undervalued On Sales But Weaker On Broader Checks

DraftKings stock has had a tough run over the past few years, yet some valuation checks now point to it trading on the cheaper side of the sector. That mix of weak long term returns and pockets of apparent value is what current investors are trying to make sense of. DraftKings shareholders have seen the stock decline 59.4% over the past 5 years, which sets a cautious backdrop for any argument that the current share price already discounts the main risks. Expectations around how profitably...
NYSE:FDS
NYSE:FDSCapital Markets

Is FactSet Research Systems (FDS) Fairly Valued After Expanding Its RepRisk Partnership?

FactSet Research Systems (FDS) has drawn fresh attention after expanding its collaboration with RepRisk AG, selecting the firm as its preferred partner for sustainable investing products and business conduct risk data across multiple investment workflows. See our latest analysis for FactSet Research Systems. Set against these partnerships and leadership changes, FactSet Research Systems has seen a 22.79% 90 day share price return, even as the 1 year total shareholder return has declined...
NasdaqGS:TRMK
NasdaqGS:TRMKBanks

Trustmark (TRMK) Earnings Put Fair Value Back In Focus

Trustmark (TRMK) has drawn fresh attention after a busy late July update. The bank reported second quarter and first half 2026 results, affirmed a quarterly dividend, disclosed higher net charge offs, and outlined recent share repurchases. See our latest analysis for Trustmark. Trustmark's recent earnings beat, higher dividend visibility and completion of its buyback program have come alongside a 90 day share price return of 7.11% and a year to date share price return of 22.56%. The 1 year...
NYSE:ACEL
NYSE:ACELHospitality

How Investors May Respond To Accel Entertainment (ACEL) Profit Gains And Disciplined Capital Allocation Choices

In the second quarter of 2026, Accel Entertainment, Inc. reported higher year-over-year sales, revenue, and net income, while also repurchasing approximately 500,000 shares for US$5.6 million and ending the period with about US$255 million in cash, net debt of roughly US$318 million, and an undrawn US$300 million credit facility. Management emphasized a disciplined, returns-focused capital allocation approach, highlighting the company’s capacity to fund organic investment, pursue...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line Holdings (NCLH) Could Be 11% Undervalued Following Soft Demand Concerns

Why Norwegian Cruise Line Holdings Stock Is Back In Focus Norwegian Cruise Line Holdings (NCLH) has drawn renewed attention after a recent analyst note flagged softer near term demand and heavier promotional activity, despite the company posting stronger quarterly earnings and operating metrics. See our latest analysis for Norwegian Cruise Line Holdings. The recent analyst comments on softer near term demand sit against a mixed share price picture for Norwegian Cruise Line Holdings. The 90...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA) Stock Holds Steady As Losses Deepen

Vanda Pharmaceuticals stock barely budged after earnings, up about 0.5% to around US$5, even though the quarter underscored how hard the current build out is hitting the income statement. The headline is simple: revenue held around US$50.5m while the Q2 net loss widened to US$62.5m as spending on late stage trials and new launches weighed heavily. Investors came into this print after a tough stretch, with the stock down about 20% over the past month. The key question now is how long the...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Is Fastly (FSLY) Above Fair Value After Its 204% Run?

Fastly stock has delivered a sharp rerating over the past year, yet the current valuation checks point to a company that screens as expensive rather than a clear bargain. Fastly has returned 204.0% over the past year, which puts more pressure on today’s buyers to justify the higher entry price. The company’s role in Experian’s Agent Trust ecosystem can support growth expectations around AI related traffic, while any disappointment in monetizing this kind of partnership may weigh heavily on...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Microsoft (MSFT) Opens Its Largest India Data Center Hub

Microsoft (NasdaqGS:MSFT) has opened its largest India data center hub, aimed at expanding its cloud and AI footprint in the country. The build out represents a long term, multi billion dollar commitment to India as a cloud and AI infrastructure market. LegalZoom and Paychex are integrating their AI agents and services directly into Microsoft 365 Copilot for legal and HR workflows. The new partnerships highlight how Copilot is becoming a central platform for applied AI across enterprise...
NasdaqGS:EDIT
NasdaqGS:EDITBiotechs

Editas Medicine (EDIT) Stock Rallies On Revenue Jump But Losses Linger

Traders nudged Editas Medicine up about 5% today, which looks like a cautious, rather than euphoric, vote on a tricky set of numbers. The stock came into this report under pressure over the past month, so even a small relief move matters. The headline is margin pain meeting revenue progress. Total revenue for the quarter sat at US$11.89 million while the company still reported a loss with basic earnings per share at US$0.15 in the red. The real question now is whether this mix justifies...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Computing (RGTI) Could Be 3% Overvalued On Q2 Earnings And Quantum Deals

Rigetti Computing (RGTI) is back in focus after its second quarter 2026 earnings report, which combined strong year over year revenue growth with a wider loss and several high profile quantum computing partnership updates. See our latest analysis for Rigetti Computing. Rigetti Computing’s share price has fallen 30% year to date, even after an 11% 7 day share price return following the earnings release and recent government and HPE partnership announcements, while the 3 year total shareholder...
NYSE:LEG
NYSE:LEGConsumer Durables

How Investors Are Reacting To Leggett & Platt (LEG) Weaker Q2 Results And Lower Dividend

Leggett & Platt recently reported its second-quarter 2026 results, with sales of US$999.7 million and net income of US$47.1 million, both lower than a year earlier, and declared a third-quarter dividend of US$0.05 per share payable on August 24, 2026. The combination of softer revenue and earnings for both the quarter and first half of 2026 highlights ongoing pressure on profitability despite the continued dividend payout. With second-quarter sales and earnings declining year over year,...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

Sandisk (SNDK) Stock Drops As Profit Surge Meets Valuation Doubts

Sandisk stock closed down 6.8% at US$1,258.58, capping a tough month for holders after a double digit slide over 30 days. That reaction sits awkwardly next to a quarter where revenue hit US$8.97b and non GAAP earnings per share jumped to US$39.25, both ahead of management guidance. The real focus is not today’s drop but what this earnings release suggests about the multi year arc. Sandisk has moved from losses to a full year of profit and now trades on a trailing P/E of 16.4x, while a...
OTCPK:NASB
OTCPK:NASBBanks

NASB Financial (NASB) Stock Slips As Profitability Strength Raises Valuation Questions

NASB Financial slipped about 1% today, even though the latest quarter showed the kind of earnings power many regional banks would welcome. Basic earnings per share for Q3 landed at roughly US$1.48 on revenue of about US$24.8 million, contributing to a trailing 12 month P/E of 8.4x that currently sits below the broader US banks sector and wider market. For short term traders the red screen might stand out. For longer term investors the focus is on the sustained profitability and the relatively...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia (EXPE) Stock Slips As Margin Gains Meet Profit Taking

Expedia Group just served up the kind of quarter that usually earns a celebration, yet the stock slipped 4.1% to about US$306 after the report. The gap between the reaction and the results is striking. Revenue for Q2 came in at US$4.3b and adjusted EBITDA margin reached 25.9%, with management confident enough to lift full year margin expansion targets. Investors came into this print after a strong three month run in the stock. Today’s move suggests profit taking and nerves, while the earnings...
NasdaqGM:ALNT
NasdaqGM:ALNTElectrical

Allient (ALNT) Stock Price Surges As Margin Gains Reset The Story

Allient just ripped 19.3% higher in a single session, and that kind of move always raises the same question: Is this emotion or earnings talking? Coming into the print, the stock was already on a tear over the past quarter, and the valuation looked stretched on a P/E that sat well above peers. The headline this time is profit power. Quarterly basic earnings per share reached about US$0.62 on revenue of roughly US$153.8m, with trailing net income roughly doubling over the past year and net...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

BeOne Medicines (ONC) Earnings Beat And Higher Guidance Leave Valuation In Focus

BeOne Medicines (ONC) stock is in focus after the company reported second quarter 2026 earnings and raised its full year revenue and GAAP operating income guidance on 5 August 2026. See our latest analysis for BeOne Medicines. The latest earnings surprise and higher 2026 guidance appear to be feeding into BeOne Medicines' momentum, with a 30-day share price return of 6.75% and a 1-year total shareholder return of 10.56%. The 3-year total shareholder return of 66.63% reflects a stronger long...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Pegasystems (PEGA) Could Be 47% Undervalued After Its FedRAMP Cloud Expansion

Why Pegasystems stock is in focus after the latest FedRAMP move Pegasystems (PEGA) is back on investors’ radar after expanding its FedRAMP Class D Certified capabilities within Pega Cloud for Government, widening access to its AI-driven workflow and decisioning tools for U.S. federal agencies. See our latest analysis for Pegasystems. At a share price of US$31.67, Pegasystems has seen short term momentum pick up with a 7 day share price return of 5.46%, although the share price is still down...
NYSE:COLD
NYSE:COLDIndustrial REITs

How Americold’s Q2 2026 Impairment-Driven Loss Will Impact Americold Realty Trust (COLD) Investors

In the second quarter of 2026, Americold Realty Trust, Inc. reported revenue of US$662.89 million but recorded a net loss of US$342.81 million, largely reflecting a very large impairment of long-lived assets. This swing from a small profit a year earlier to a sizeable loss, despite relatively steady sales, points to a significant reassessment of asset values rather than a sharp decline in underlying demand. We’ll now examine how this sizable impairment-driven loss affects Americold’s...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

BioMarin Pharmaceutical (BMRN) Could Be 30% Below Fair Value On Raised Guidance

BioMarin Pharmaceutical (BMRN) has just released its second quarter 2026 results, giving investors fresh detail on how revenue, earnings and guidance are evolving after its rare disease expansion. See our latest analysis for BioMarin Pharmaceutical. BioMarin Pharmaceutical’s Q2 earnings release and raised guidance have come alongside a 13.69% 90 day share price return and a modest 3.38% year to date share price return, while the 3 year total shareholder return has declined 32.39%, showing...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

What Could Marvell Technology (MRVL) Gain From Its Expanded AI Memory Push?

Marvell Technology (NasdaqGS: MRVL) announced a major expansion of its AI memory infrastructure portfolio, targeting hyperscalers and cloud providers. The new Bravera SC6 PCIe 6.0 SSD controller is designed for server-level AI storage in high performance data centers. Structera X memory expansion products support rack scale CXL memory and pod level optical shared memory to address AI data center bottlenecks. The launch positions Marvell as a more central supplier for customers running large...
NasdaqGS:PRDO
NasdaqGS:PRDOConsumer Services

How Stronger Q2 2026 Earnings Will Impact Perdoceo Education (PRDO) Investors

In the past quarter, Perdoceo Education Corporation reported second-quarter 2026 results with revenue of US$213.36 million and net income of US$47.97 million, both higher than a year earlier, alongside an increase in diluted earnings per share from continuing operations to US$0.75. Across the first half of 2026, the company’s revenue rose to US$435.10 million and net income to US$101.92 million, underscoring stronger profitability and earnings per share improvements from continuing...
NYSE:GLOB
NYSE:GLOBIT

Is Globant (GLOB) A Bargain On Its Glob.AI Launch?

Globant (GLOB) is drawing fresh attention after launching Glob.AI, an AI native services platform that uses consumption based pricing and task specific AI Pods supported by human experts for enterprise clients. See our latest analysis for Globant. Despite the launch of Glob.AI and its focus on AI-native services, Globant’s share price has had mixed momentum, with a 30-day share price return of 17.69% but a year-to-date share price decline of 40.94%, alongside a 1-year total shareholder return...